Henry Biza - FutureWorld Corp Chief Scientific
Insider
Henry Biza is Chief Scientific of FutureWorld Corp
Phone | 727-474-1816 |
Web | http://www.futureworldcorp.com |
FutureWorld Corp Management Efficiency
FutureWorld Corp's management efficiency ratios could be used to measure how well FutureWorld Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Jake Graves | Cresco Labs | N/A | |
Zach Marburger | Cresco Labs | 38 | |
Dennis Olis | Cresco Labs | 60 | |
CPA CPA | Journey Medical Corp | 69 | |
Timothy Emberg | OrganiGram Holdings | N/A | |
CPA CPA | OrganiGram Holdings | 55 | |
Impola Kelli | Cresco Labs | N/A | |
Ty Gent | Cresco Labs | 64 | |
Tina Shannon | OrganiGram Holdings | N/A | |
Robert Nevin | Journey Medical Corp | 56 | |
Stephan Bankosz | Vext Science | N/A | |
Geoff Riggs | OrganiGram Holdings | N/A | |
Beena Goldenberg | OrganiGram Holdings | 60 | |
Eric Offenberger | Vext Science | N/A | |
Robyn Hunter | Journey Medical Corp | N/A | |
Amy Schwalm | OrganiGram Holdings | N/A | |
Gregory Engel | OrganiGram Holdings | 59 | |
CFA CA | OrganiGram Holdings | 51 | |
John Schetz | Cresco Labs | 46 | |
Ernest Galvan | Journey Medical Corp | 62 | |
Jonathan Ross | Vext Science | N/A |
Management Performance
Return On Equity | -0.0196 | |||
Return On Asset | -0.0096 |
FutureWorld Corp Leadership Team
Elected by the shareholders, the FutureWorld Corp's board of directors comprises two types of representatives: FutureWorld Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FutureWorld. The board's role is to monitor FutureWorld Corp's management team and ensure that shareholders' interests are well served. FutureWorld Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FutureWorld Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Verghese, Chief Hemptech | ||
David McCarthy, Ex VP | ||
Terry Gardner, VP Corp | ||
Saeed Talari, Chairman Officer | ||
Douglass Wright, CoFounder | ||
Bobban Subhadra, Chief Sciences | ||
Karin Rohret, Controller | ||
Henry Biza, Chief Scientific | ||
Sam Khan, VP Marketing |
FutureWorld Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is FutureWorld Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0196 | |||
Return On Asset | -0.0096 | |||
Operating Margin | (2.79) % | |||
Current Valuation | 565.08 K | |||
Shares Outstanding | 5.19 B | |||
Price To Sales | 0.02 X | |||
EBITDA | (682.31 K) | |||
Net Income | (644.32 K) | |||
Cash And Equivalents | (1.44 K) | |||
Total Debt | (384.54 K) |
Currently Active Assets on Macroaxis
Other Information on Investing in FutureWorld Pink Sheet
FutureWorld Corp financial ratios help investors to determine whether FutureWorld Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FutureWorld with respect to the benefits of owning FutureWorld Corp security.